↗4 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$4.4MSold on the market
1Companies
Sep 21, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 21, 202618:21 | Sep 17, 2026 | BBIOBridgeBio Pharma, Inc. | Chief Executive Officer, Director | S · Sell10b5-1 | $69.08 | −10,000 | 495,686 | -2% | −$691K | ||
| Aug 20, 202616:31 | Aug 19, 2026from Aug 18, 2026 | BBIOBridgeBio Pharma, Inc. | Chief Executive Officer, Director | S · Sell10b5-1 | $82.86 | −44,980 | 243,327 | -16% | −$3.7M | ||
| Aug 18, 202618:02 | Aug 16, 2026 | BBIOBridgeBio Pharma, Inc. | Chief Executive Officer, Director | M · Exercise | — | +71,217 | 314,544 | +29% | — | ||
| Aug 18, 202618:02 | Aug 16, 2026 | BBIOBridgeBio Pharma, Inc. | Chief Executive Officer, Director | F · Tax | $79.86 | −36,237 | 278,307 | -12% | $2.9M |